{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T01:14:31Z","timestamp":1793150071383,"version":"4.5.0"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004396","name":"Thailand Research Fund","doi-asserted-by":"publisher","award":["RTA6080003"],"award-info":[{"award-number":["RTA6080003"]}],"id":[{"id":"10.13039\/501100004396","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004987","name":"State Corporation Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004987","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004192","name":"National Science and Technology Development Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004192","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002842","name":"Chiang Mai University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002842","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.phrs.2019.104542","type":"journal-article","created":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T19:49:16Z","timestamp":1573588156000},"page":"104542","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":85,"special_numbering":"C","title":["Doxorubicin and its proarrhythmic effects: A comprehensive review of the evidence from experimental and clinical studies"],"prefix":"10.1016","volume":"151","author":[{"given":"Juthipong","family":"Benjanuwattra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natthaphat","family":"Siri-Angkul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siriporn C.","family":"Chattipakorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nipon","family":"Chattipakorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.phrs.2019.104542_bib0005","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.phrs.2019.104542_bib0010","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.2042-7158.2012.01567.x","article-title":"Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems","volume":"65","author":"Tacar","year":"2013","journal-title":"J. Pharm. Pharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2019.104542_bib0015","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S1734-1140(09)70018-0","article-title":"Anthracycline-induced cardiotoxicity: overview of studies examining the roles of oxidative stress and free cellular iron","volume":"61","author":"Simunek","year":"2009","journal-title":"Pharmacol. Rep."},{"issue":"5","key":"10.1016\/j.phrs.2019.104542_bib0020","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/emm.2006.63","article-title":"Doxorubicin-induced reactive oxygen species generation and intracellular Ca2+ increase are reciprocally modulated in rat cardiomyocytes","volume":"38","author":"Kim","year":"2006","journal-title":"Exp. Mol. Med."},{"issue":"14","key":"10.1016\/j.phrs.2019.104542_bib0025","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1200\/JCO.2008.21.1425","article-title":"Late mortality among 5-year survivors of childhood cancer: a summary from the childhood cancer survivor Study","volume":"27","author":"Armstrong","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.phrs.2019.104542_bib0030","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1002\/cncr.11407","article-title":"Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials","volume":"97","author":"Swain","year":"2003","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.phrs.2019.104542_bib0035","doi-asserted-by":"crossref","first-page":"214","DOI":"10.2174\/157340311799960645","article-title":"Anthracycline cardiotoxicity: prevalence, pathogenesis and treatment","volume":"7","author":"Volkova","year":"2011","journal-title":"Curr. Cardiol. Rev."},{"issue":"1","key":"10.1016\/j.phrs.2019.104542_bib0040","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/med.21280","article-title":"Doxorubicin-induced cardiotoxicity: from bioenergetic failure and cell death to cardiomyopathy","volume":"34","author":"Carvalho","year":"2014","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.phrs.2019.104542_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tiv.2018.05.001","article-title":"Doxorubicin-induced mitophagy and mitochondrial damage is associated with dysregulation of the PINK1\/parkin pathway","volume":"51","author":"Yin","year":"2018","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.phrs.2019.104542_bib0050","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ejphar.2017.10.043","article-title":"Molecular mechanism of doxorubicin-induced cardiomyopathy - an update","volume":"818","author":"Renu","year":"2018","journal-title":"Eur. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.phrs.2019.104542_bib0055","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1089\/ars.2012.4818","article-title":"Redox regulation of sodium and calcium handling","volume":"18","author":"Wagner","year":"2013","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.phrs.2019.104542_bib0060","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3389\/fphys.2016.00313","article-title":"Reactive oxygen species, endoplasmic reticulum stress and mitochondrial dysfunction: the link with cardiac arrhythmogenesis","volume":"7","author":"Tse","year":"2016","journal-title":"Front. Physiol."},{"issue":"1","key":"10.1016\/j.phrs.2019.104542_bib0065","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0002-9149(92)91393-I","article-title":"Electrocardiographic changes and arrhythmias after cancer therapy in children and young adults","volume":"70","author":"Larsen","year":"1992","journal-title":"Am. J. Cardiol."},{"issue":"3","key":"10.1016\/j.phrs.2019.104542_bib0070","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/01.smj.0000257382.89910.fe","article-title":"Early and late arrhythmogenic effects of doxorubicin","volume":"100","author":"Kilickap","year":"2007","journal-title":"South. Med. J."},{"issue":"7","key":"10.1016\/j.phrs.2019.104542_bib0075","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3109\/02841869109091832","article-title":"Cardiac arrhythmias in patients with small cell lung cancer and cardiac disease before, during and after doxorubicin administration. An evaluation of acute cardiotoxicity by continuous 24-hour Holter monitoring","volume":"30","author":"Raabe","year":"1991","journal-title":"Acta Oncol."},{"issue":"3","key":"10.1016\/j.phrs.2019.104542_bib0080","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.eupc.2004.12.012","article-title":"Doxorubicin-induced second degree and complete atrioventricular block","volume":"7","author":"Kilickap","year":"2005","journal-title":"Europace"},{"issue":"5","key":"10.1016\/j.phrs.2019.104542_bib0085","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/europace\/eum033","article-title":"Doxorubicin-induced ventricular arrhythmia treated by implantation of an automatic cardioverter-defibrillator","volume":"9","author":"Rudzinski","year":"2007","journal-title":"Europace"},{"issue":"11","key":"10.1016\/j.phrs.2019.104542_bib0090","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26556","article-title":"Electrophysiological effects of anthracyclines in adult survivors of pediatric malignancy","volume":"64","author":"Markman","year":"2017","journal-title":"Pediatr. Blood Cancer"},{"issue":"1","key":"10.1016\/j.phrs.2019.104542_bib0095","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.hrthm.2009.08.005","article-title":"Cardiac ion channels in health and disease","volume":"7","author":"Amin","year":"2010","journal-title":"Heart Rhythm"},{"issue":"1","key":"10.1016\/j.phrs.2019.104542_bib0100","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ccep.2010.10.012","article-title":"Overview of basic mechanisms of cardiac arrhythmia","volume":"3","author":"Antzelevitch","year":"2011","journal-title":"Card. Electrophysiol. Clin."},{"issue":"2\u20133","key":"10.1016\/j.phrs.2019.104542_bib0105","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.pbiomolbio.2008.10.008","article-title":"Dispersions of repolarization and ventricular arrhythmogenesis: lessons from animal models","volume":"98","author":"Killeen","year":"2008","journal-title":"Prog. Biophys. Mol. Biol."},{"issue":"9","key":"10.1016\/j.phrs.2019.104542_bib0110","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.amjcard.2016.07.049","article-title":"Prognostic significance of new-onset atrial fibrillation in patients with Non-Hodgkin\u2019s lymphoma treated with anthracyclines","volume":"118","author":"Amioka","year":"2016","journal-title":"Am. J. Cardiol."},{"issue":"16","key":"10.1016\/j.phrs.2019.104542_bib0115","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1161\/CIRCULATIONAHA.113.003313","article-title":"Oxidized Ca(2+)\/calmodulin-dependent protein kinase II triggers atrial fibrillation","volume":"128","author":"Purohit","year":"2013","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.phrs.2019.104542_bib0120","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1046\/j.1365-2796.1999.00480.x","article-title":"QT dispersion and late potentials during doxorubicin therapy for non-Hodgkin\u2019s lymphoma","volume":"245","author":"Nousiainen","year":"1999","journal-title":"J. Intern. Med."},{"issue":"2","key":"10.1016\/j.phrs.2019.104542_bib0125","first-page":"115","article-title":"Assessment of anthracycline-induced cardiotoxicity with electrocardiography","volume":"31","author":"Horacek","year":"2009","journal-title":"Exp. Oncol."},{"issue":"5","key":"10.1016\/j.phrs.2019.104542_bib0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0196763","article-title":"Effects of anthracycline, cyclophosphamide and taxane chemotherapy on QTc measurements in patients with breast cancer","volume":"13","author":"Veronese","year":"2018","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.phrs.2019.104542_bib0135","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/BF02766801","article-title":"Ventricular repolarization time indexes following anthracycline treatment","volume":"12","author":"Sarubbi","year":"1997","journal-title":"Heart Vessels"},{"issue":"1","key":"10.1016\/j.phrs.2019.104542_bib0140","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/00005344-198401000-00028","article-title":"Doxorubicin cardiotoxicity in the rat: comparison of electrocardiogram, transmembrane potential, and structural effects","volume":"6","author":"Jensen","year":"1984","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2019.104542_bib0145","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s00395-006-0609-0","article-title":"Reduced repolarization reserve due to anthracycline therapy facilitates torsade de pointes induced by IKr blockers","volume":"102","author":"Milberg","year":"2007","journal-title":"Basic Res. Cardiol."},{"issue":"1","key":"10.1016\/j.phrs.2019.104542_bib0150","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1476-5381.2009.00371.x","article-title":"Dexrazoxane protects the heart from acute doxorubicin-induced QT prolongation: a key role for I(Ks)","volume":"159","author":"Ducroq","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.phrs.2019.104542_bib0155","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1472-8206.2012.01037.x","article-title":"Remodeling of ventricular repolarization in a chronic doxorubicin cardiotoxicity rat model","volume":"27","author":"Kharin","year":"2013","journal-title":"Fundam. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.phrs.2019.104542_bib0160","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF00686399","article-title":"Reducing doxorubicin cardiotoxicity in the rat using deferred treatment with ADR-529","volume":"30","author":"Agen","year":"1992","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"10","key":"10.1016\/j.phrs.2019.104542_bib0165","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1248\/bpb.34.1523","article-title":"Electrocardiographic and biochemical evidence for the cardioprotective effect of antioxidants in acute doxorubicin-induced cardiotoxicity in the beagle dogs","volume":"34","author":"Xin","year":"2011","journal-title":"Biol. Pharm. Bull."},{"issue":"3","key":"10.1016\/j.phrs.2019.104542_bib0170","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s11596-012-0058-y","article-title":"Effect of oxidative stress on ventricular arrhythmia in rabbits with adriamycin-induced cardiomyopathy","volume":"32","author":"He","year":"2012","journal-title":"J. Huazhong Univ. Sci. Technol. Med. Sci."},{"issue":"2","key":"10.1016\/j.phrs.2019.104542_bib0175","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0008-6363(96)00080-6","article-title":"Arrhythmogenesis in experimental models of heart failure: the role of increased load","volume":"32","author":"Pye","year":"1996","journal-title":"Cardiovasc. Res."},{"issue":"10","key":"10.1016\/j.phrs.2019.104542_bib0180","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18102121","article-title":"Cardiotoxic effects of short-term doxorubicin administration: involvement of connexin 43 in calcium impairment","volume":"18","author":"Pecoraro","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.phrs.2019.104542_bib0185","doi-asserted-by":"crossref","first-page":"H1762","DOI":"10.1152\/ajpheart.00346.2004","article-title":"Altered connexin43 expression produces arrhythmia substrate in heart failure","volume":"287","author":"Poelzing","year":"2004","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.phrs.2019.104542_bib0190","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3389\/fphar.2014.00048","article-title":"CaMKII in sinoatrial node physiology and dysfunction","volume":"5","author":"Wu","year":"2014","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.phrs.2019.104542_bib0195","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.yjmcc.2011.07.016","article-title":"CaMKII-dependent SR Ca leak contributes to doxorubicin-induced impaired Ca handling in isolated cardiac myocytes","volume":"51","author":"Sag","year":"2011","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"4","key":"10.1016\/j.phrs.2019.104542_bib0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0215992","article-title":"CaMKII activation participates in doxorubicin cardiotoxicity and is attenuated by moderate GRP78 overexpression","volume":"14","author":"Tscheschner","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.phrs.2019.104542_bib0205","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1161\/CIRCRESAHA.108.183475","article-title":"Oxidative-stress-induced afterdepolarizations and calmodulin kinase II signaling","volume":"104","author":"Xie","year":"2009","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.phrs.2019.104542_bib0210","first-page":"221","article-title":"Absorption and tissue distribution of doxorubicin entrapped in liposomes following intravenous or intraperitoneal administration","volume":"26","author":"Rosa","year":"1983","journal-title":"Pharmacology"},{"issue":"3","key":"10.1016\/j.phrs.2019.104542_bib0215","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0008-6363(98)00034-0","article-title":"Free radical involvement in doxorubicin-induced electrophysiological alterations in rat papillary muscle fibres","volume":"38","author":"Venditti","year":"1998","journal-title":"Cardiovasc. Res."},{"issue":"8","key":"10.1016\/j.phrs.2019.104542_bib0220","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1093\/cvr\/14.8.446","article-title":"Adriamycin-induced alterations of the action potential in rat papillary muscle","volume":"14","author":"Lazarus","year":"1980","journal-title":"Cardiovasc. Res."},{"issue":"4","key":"10.1016\/j.phrs.2019.104542_bib0225","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1161\/01.RES.76.4.645","article-title":"Effects of doxorubicin on excitation-contraction coupling in guinea pig ventricular myocardium","volume":"76","author":"Wang","year":"1995","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.phrs.2019.104542_bib0230","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1161\/01.RES.53.5.655","article-title":"The effects of adriamycin on normal and ouabain-toxic canine Purkinje and ventricular muscle fibers","volume":"53","author":"Binah","year":"1983","journal-title":"Circ. Res."},{"issue":"7","key":"10.1016\/j.phrs.2019.104542_bib0235","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/cvr\/24.7.591","article-title":"Chronic doxorubicin induced cardiomyopathy in rabbits: mechanical, intracellular action potential, and beta adrenergic characteristics of the failing myocardium","volume":"24","author":"Shenasa","year":"1990","journal-title":"Cardiovasc. Res."},{"issue":"4","key":"10.1016\/j.phrs.2019.104542_bib0240","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0022-2828(81)90281-9","article-title":"Adriamycin Cardiotoxicity: possible pathogenic mechanisms","volume":"13","author":"Azuma","year":"1981","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"4","key":"10.1016\/j.phrs.2019.104542_bib0245","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/cvr\/24.4.309","article-title":"Electrophysiological changes in animal model of chronic cardiac failure","volume":"24","author":"Doherty","year":"1990","journal-title":"Cardiovasc. Res."},{"issue":"2","key":"10.1016\/j.phrs.2019.104542_bib0250","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0008-6363(99)00360-0","article-title":"Heterogeneous changes in action potential and intracellular Ca2+ in left ventricular myocyte sub-types from rabbits with heart failure","volume":"45","author":"McIntosh","year":"2000","journal-title":"Cardiovasc. Res."},{"issue":"3","key":"10.1016\/j.phrs.2019.104542_bib0255","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1161\/01.RES.76.3.325","article-title":"Functional consequences of sulfhydryl modification in the pore-forming subunits of cardiovascular Ca2+ and Na+ channels","volume":"76","author":"Chiamvimonvat","year":"1995","journal-title":"Circ. Res."},{"issue":"8","key":"10.1016\/j.phrs.2019.104542_bib0260","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1161\/CIRCRESAHA.110.220673","article-title":"Reactive oxygen species originating from mitochondria regulate the cardiac sodium channel","volume":"107","author":"Liu","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2019.104542_bib0265","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.yjmcc.2012.10.011","article-title":"Mitochondrial dysfunction causing cardiac sodium channel downregulation in cardiomyopathy","volume":"54","author":"Liu","year":"2013","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"3","key":"10.1016\/j.phrs.2019.104542_bib0270","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.hrthm.2016.12.026","article-title":"Role of protein kinase C in metabolic regulation of the cardiac Na(+) channel","volume":"14","author":"Liu","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.phrs.2019.104542_bib0275","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.yjmcc.2018.11.019","article-title":"Progression of excitation-contraction coupling defects in doxorubicin cardiotoxicity","volume":"126","author":"Llach","year":"2019","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"2","key":"10.1016\/j.phrs.2019.104542_bib0280","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1006\/jmcc.1994.1019","article-title":"Effects of adriamycin on ionic currents in single cardiac myocytes of the rabbit","volume":"26","author":"Earm","year":"1994","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"33","key":"10.1016\/j.phrs.2019.104542_bib0285","doi-asserted-by":"crossref","first-page":"15851","DOI":"10.1016\/S0021-9258(18)47666-1","article-title":"The major metabolite of doxorubicin is a potent inhibitor of membrane-associated ion pumps. A correlative study of cardiac muscle with isolated membrane fractions","volume":"262","author":"Boucek","year":"1987","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.phrs.2019.104542_bib0290","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1172\/JCI115241","article-title":"L-type cardiac calcium channels in doxorubicin cardiomyopathy in rats morphological, biochemical, and functional correlations","volume":"87","author":"Keung","year":"1991","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.phrs.2019.104542_bib0295","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.yjmcc.2008.03.011","article-title":"Oxidoreductase regulation of Kv currents in rat ventricle","volume":"44","author":"Liang","year":"2008","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"4","key":"10.1016\/j.phrs.2019.104542_bib0300","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1124\/mol.114.093849","article-title":"Adverse effects of doxorubicin and its metabolic product on cardiac RyR2 and SERCA2A","volume":"86","author":"Hanna","year":"2014","journal-title":"Mol. Pharmacol."},{"issue":"4","key":"10.1016\/j.phrs.2019.104542_bib0305","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1161\/01.CIR.84.4.1773","article-title":"Cellular electrophysiological basis for oxygen radical-induced arrhythmias. A patch-clamp study in guinea pig ventricular myocytes","volume":"84","author":"Cerbai","year":"1991","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.phrs.2019.104542_bib0310","doi-asserted-by":"crossref","first-page":"H416","DOI":"10.1152\/ajpheart.91446.2007","article-title":"Regulation of Kv4 channel expression in failing rat heart by the thioredoxin system","volume":"295","author":"Li","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"19","key":"10.1016\/j.phrs.2019.104542_bib0315","doi-asserted-by":"crossref","first-page":"5369","DOI":"10.1113\/JP272262","article-title":"Voltage-gated calcium channels and their auxiliary subunits: physiology and pathophysiology and pharmacology","volume":"594","author":"Dolphin","year":"2016","journal-title":"J. Physiol."},{"issue":"11","key":"10.1016\/j.phrs.2019.104542_bib0320","doi-asserted-by":"crossref","first-page":"4996","DOI":"10.1073\/pnas.0913760107","article-title":"CaV1.2 beta-subunit coordinates CaMKII-triggered cardiomyocyte death and afterdepolarizations","volume":"107","author":"Koval","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.phrs.2019.104542_bib0325","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1124\/jpet.106.101832","article-title":"Blocking late sodium current reduces hydrogen peroxide-induced arrhythmogenic activity and contractile dysfunction","volume":"318","author":"Song","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"5","key":"10.1016\/j.phrs.2019.104542_bib0330","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1161\/CIRCRESAHA.110.221911","article-title":"Reactive oxygen species-activated Ca\/calmodulin kinase IIdelta is required for late I(Na) augmentation leading to cellular Na and Ca overload","volume":"108","author":"Wagner","year":"2011","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.phrs.2019.104542_bib0335","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1161\/CIRCRESAHA.107.166678","article-title":"Reactive oxygen species-induced activation of p90 ribosomal S6 kinase prolongs cardiac repolarization through inhibiting outward K+ channel activity","volume":"103","author":"Lu","year":"2008","journal-title":"Circ. Res."},{"issue":"Pt 1","key":"10.1016\/j.phrs.2019.104542_bib0340","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1113\/jphysiol.2002.026468","article-title":"Regulation of cardiac excitation-contraction coupling by action potential repolarization: role of the transient outward potassium current (I(to))","volume":"546","author":"Sah","year":"2003","journal-title":"J. Physiol."},{"issue":"6868","key":"10.1016\/j.phrs.2019.104542_bib0345","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/415198a","article-title":"Cardiac excitation-contraction coupling","volume":"415","author":"Bers","year":"2002","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.phrs.2019.104542_bib0350","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1006\/jmcc.1997.0588","article-title":"Sarcoplasmic reticulum genes are selectively down-regulated in cardiomyopathy produced by doxorubicin in rabbits","volume":"30","author":"Arai","year":"1998","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"3","key":"10.1016\/j.phrs.2019.104542_bib0355","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1385\/CT:5:3:269","article-title":"Doxorubicin cardiac dysfunction: effects on calcium regulatory proteins, sarcoplasmic reticulum, and triiodothyronine","volume":"5","author":"Olson","year":"2005","journal-title":"Cardiovasc. Toxicol."},{"issue":"12","key":"10.1016\/j.phrs.2019.104542_bib0360","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1161\/01.RES.0000194329.41863.89","article-title":"Ca2+\/calmodulin-dependent protein kinase modulates cardiac ryanodine receptor phosphorylation and sarcoplasmic reticulum Ca2+ leak in heart failure","volume":"97","author":"Ai","year":"2005","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.phrs.2019.104542_bib0365","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1006\/bbrc.2002.6380","article-title":"Doxorubicin and C-13 deoxydoxorubicin effects on ryanodine receptor gene expression","volume":"291","author":"Gambliel","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"8","key":"10.1016\/j.phrs.2019.104542_bib0370","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1006\/jmcc.1999.0972","article-title":"Persistent effects of doxorubicin on cardiac gene expression","volume":"31","author":"Boucek","year":"1999","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"12","key":"10.1016\/j.phrs.2019.104542_bib0375","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1161\/CIRCRESAHA.116.304678","article-title":"Role of sodium and calcium dysregulation in tachyarrhythmias in sudden cardiac death","volume":"116","author":"Wagner","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2019.104542_bib0380","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.3389\/fphys.2018.01775","article-title":"Redox dependent modifications of ryanodine receptor: basic mechanisms and implications in heart diseases","volume":"9","author":"Nikolaienko","year":"2018","journal-title":"Front. Physiol."},{"issue":"1\u20133","key":"10.1016\/j.phrs.2019.104542_bib0385","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejphar.2010.08.001","article-title":"Potential adverse interaction of human cardiac calsequestrin","volume":"646","author":"Kang","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2019.104542_bib0390","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.2147\/OTT.S162003","article-title":"Comparable efficacy and less toxicity of pegylated liposomal doxorubicin versus epirubicin for neoadjuvant chemotherapy of breast cancer: a case-control study","volume":"11","author":"Dong","year":"2018","journal-title":"Onco. Ther."},{"issue":"5","key":"10.1016\/j.phrs.2019.104542_bib0395","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1200\/JCO.2001.19.5.1444","article-title":"Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized, multicenter trial of metastatic breast cancer","volume":"19","author":"Batist","year":"2001","journal-title":"J. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.phrs.2019.104542_bib0400","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1006\/jmcc.1997.0563","article-title":"Characterisation of a cellular model of cardiomyopathy, in the rabbit, produced by chronic administration of the anthracycline, epirubicin","volume":"29","author":"Kelso","year":"1997","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"3","key":"10.1016\/j.phrs.2019.104542_bib0405","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0058421","article-title":"Comparative cardiac toxicity of anthracyclines in vitro and in vivo in the mouse","volume":"8","author":"Toldo","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.phrs.2019.104542_bib0410","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nm.4087","article-title":"Human induced pluripotent stem cell-derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity","volume":"22","author":"Burridge","year":"2016","journal-title":"Nat. Med."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661819321966?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661819321966?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T21:41:42Z","timestamp":1778794902000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661819321966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":82,"alternative-id":["S1043661819321966"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2019.104542","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Doxorubicin and its proarrhythmic effects: A comprehensive review of the evidence from experimental and clinical studies","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2019.104542","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104542"}}